:max_bytes(150000):strip_icc()/3231789_color1-5c0175fc46e0fb00014ab433.png "Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease")
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class…
China delivered its first domestically developed mpox vaccine into clinical trials on Monday. The vaccine,…
The National Institutes of Health has awarded Joyita Dutta, professor of biomedical engineering at the University…
In a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center,…
Recent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure…
The National Comprehensive Cancer Network (NCCN) held an oncology policy summit today in Washington, D.C.,…
Artificial Neural Networks (ANNs) can be trained to detect lung disease in premature babies by…
Post-traumatic stress disorder (PTSD) can cause an array of adverse mental health effects, but physical…
A recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of…
In brief Researchers have developed the first robotic leg powered by artificial electro-hydraulic muscles that…
